P. Kottaridis

发表

Cardiac assessment of patients for haematopoietic stem cell transplantation.

C. Handler, J. Coghlan, P. Kottaridis, 2007, Best practice & research. Clinical haematology.

The JAK2V617F tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis

L. Foroni, A. Hoffbrand, D. Patch, 2008, International journal of laboratory hematology.

Natural history of EBV replication and viral load dynamics after alemtuzumab based allogeneic stem cell transplantation.

K. Peggs, R. Hough, E. Sanchez, 2021, Transplantation and cellular therapy.

Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen.

S. Mackinnon, K. Peggs, D. Linch, 2002, Blood.

Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia

P. Vyas, C. Craddock, S. Nagra, 2010, Haematologica.

Phase I Study of High-Stringency CD8 Depletion of Donor Leukocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation

S. Mackinnon, K. Peggs, M. Lowdell, 2009, Transplantation.

The Effect of In Vivo T-Cell Depletion with Alemtuzumab on Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia.

J. Delgado, J. Miguel, J. Sierra, 2007 .

A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy.

S. Mackinnon, H. Waldmann, D. Linch, 1999 .

Rituximab Does Not Increase the Complication Rate, Particularly Perforation, When Added to Chemotherapy for Patients with Primary B-Cell Lymphomas of the Gastrointestinal Tract.

A. Goldstone, D. Hughes, A. Prentice, 2005 .

Allogeneic stem cell transplantation as treatment for myelofibrosis

S. Papageorgiou, A. Castleton, P. Kottaridis, 2006, Bone Marrow Transplantation.

Dual Glutathione‐S‐Transferase‐θ1 and ‐μ1 Gene Deletions Determine Imatinib Failure in Chronic Myeloid Leukemia

M. Pirmohamed, R. Clark, T. Holyoake, 2014, Clinical pharmacology and therapeutics.

The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study

N. Russell, G. Cook, D. Marks, 2010, Bone Marrow Transplantation.

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data

N. Russell, B. Shaw, P. Gandhi, 2011, Bone Marrow Transplantation.

Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies

D. Linch, R. Chatterjee, H. Mcgarrigle, 2002, Bone Marrow Transplantation.

S126: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. RESULTS FROM THE NCRI AML19 “MIDOTARG” PILOT TRIAL

M. Dennis, J. Cavenagh, A. Gilkes, 2022, HemaSphere.

Peripheral blood stem cell transplantation for POEMS syndrome

M. Reilly, P. Mahendra, K. Yong, 2002, Bone Marrow Transplantation.

Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation

S. Mackinnon, H. Waldmann, D. Linch, 2001, Bone Marrow Transplantation.

The Benefit of Allogeneic Transplant in 1 st Complete Remission in NPM1 Mutated AML with or without FLT3 ITD Is Restricted to Those Testing MRD Positive after Induction - an Analysis of the UK NCRI AML17 and AML19 Studies

A. Gilkes, S. Freeman, R. Dillon, 2023, Blood.